Altus Medical Contact information
Available devices
Altus Medical develops, manufactures, and markets aesthetic laser
systems for dermatologists, plastic surgeons, and other practitioners.
Their CoolGlide™ Nd:YAG laser is cleared by FDA for the
treatment of vascular lesions (leg veins) and removal of unwanted
hair on skin types I through V. They received hair removal clearance
on March 9, 2000.
CoolGlide features a ClearView Handpiece, which provides an unobstructed
view of the treatment site
Integrated contact cooling that doesn't use Cryogen or cooling
gels
SPECIFICATIONS:
- Laser Type: High Power, Long Pulse Nd:YAG
- Wavelength: 1064 nm
- Fluence: 10 - 100 J/cm (1 J/cm increments)
- Pulse Width: 10 - 100 msec (5 msec increments)
- Spot Size: 10 mm
- Repetition Rate: Single shot, 0.5, 0.8, 1.0, 1.2, 1.5, 2.0
Hz
- Epidermal Preservation: Contact Cooling
In October, 1999 Dermatology Times reported that Suzanne Kilmer,
M.D., director, Laser and Skin Surgery Center of Northern California.
Dr. Kilmer began a new study to evaluate long wavelength lasers
on patients with Fitzpatrick skin type VI.
The price of the system is $69,500.
The laser was evaluated in a three-arm study using different
fluences and pulse widths. Twenty-five patients with Fitzpatrick
skin types I-V participated in the study. There were 19 women
and six men, each of whom had four treated sites and two control
sites for a total of 100 treatment sites and 50 control sites.
The laser's safety and efficacy were measured at different intervals.
For safety, patients were evaluated at one day, one month, and
three months. After one day of treatment, mild to moderate erythema
was the most commonly found side effect appearing in 61 of 100
treated sites. Edema was reported in 15 cases, and blistering
occurred in three sites. After three months of treatment, the
safety data found no cases of erythema, edema or blistering. However,
five cases of hyperpigmentation were noticed on three patients
- two skin type IV and one skin type V. Efficacy was measured
by counting the number of hairs through digital photographs printed
at high magnification. Additionally, the sites were analyzed under
an aesthetic side-by-side evaluation of the treated site vs. the
control site.
Half of the sites was treated with a fluence of 50 J/cm and a
pulse width of 15 ms. The other half was treated with 30 ms, of
which 70 percent received 60 J/cm and 30 percent received 50 J/cm
. Results after three months of treatment showed that two of the
three arms were effective in reducing hair growth.
The median hair count reduction was 32 percent for the 60 J/cm
and 30 ms group, and 24 percent for the 50 J/cm and 15 ms group.
Under the aesthetic side-by-side evaluation, independent evaluators
preferred the post-treated sites to the pre-treated sites. "For
the two treatment parameters determined to be most effective based
on hair counts, the three month post-treatment photographs were
preferred approximately 3 to 1," Dr. Kilmer added. The study
has been extended to evaluate results at six- and 12-month intervals
and with two treatment sessions.
An article in Medical Laser Insight, Oct. '99 stated that CoolGlide's
spot size allowed practitioners to treat approximately 15 square
inches in one minute. "We lose a large percentage of our
potential clientele because laser systems have not been able to
treat darker skin types," Dr. Groot points out. "Many
laser systems haven't had enough power and depth of penetration
to target the hair follicle, which is needed for long-lasting
results."
|
|
Home 
